These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 11850804)
1. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Dinda S; Sanchez A; Moudgil V Oncogene; 2002 Jan; 21(5):761-8. PubMed ID: 11850804 [TBL] [Abstract][Full Text] [Related]
2. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells. Hurd C; Khattree N; Dinda S; Alban P; Moudgil VK Oncogene; 1997 Aug; 15(8):991-5. PubMed ID: 9285694 [TBL] [Abstract][Full Text] [Related]
3. Hormonal regulation of tumor suppressor proteins in breast cancer cells. Moudgil VK; Dinda S; Khattree N; Jhanwar S; Alban P; Hurd C J Steroid Biochem Mol Biol; 2001; 76(1-5):105-17. PubMed ID: 11384868 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of retinoblastoma protein by hormonal and antihormonal agents in T47D breast cancer cells. Alban P; Hurd C; Dinda S; Khattree N; Moudgil VK J Steroid Biochem Mol Biol; 2001 May; 77(2-3):135-41. PubMed ID: 11377979 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Murphy CS; Pink JJ; Jordan VC Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859 [TBL] [Abstract][Full Text] [Related]
6. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Pink JJ; Jordan VC Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307 [TBL] [Abstract][Full Text] [Related]
7. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines. Coradini D; Biffi A; Pirronello E; Di Fronzo G Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823 [TBL] [Abstract][Full Text] [Related]
8. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Zajchowski DA; Sager R; Webster L Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691 [TBL] [Abstract][Full Text] [Related]
9. Effects of estrogen metabolite 2-methoxyestradiol on tumor suppressor protein p53 and proliferation of breast cancer cells. Siebert AE; Sanchez AL; Dinda S; Moudgil VK Syst Biol Reprod Med; 2011 Dec; 57(6):279-87. PubMed ID: 22077725 [TBL] [Abstract][Full Text] [Related]
10. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. Hurd C; Dinda S; Khattree N; Moudgil VK Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683 [TBL] [Abstract][Full Text] [Related]
11. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Read LD; Greene GL; Katzenellenbogen BS Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242 [TBL] [Abstract][Full Text] [Related]
12. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281 [TBL] [Abstract][Full Text] [Related]
13. Effects of LY117018 (a SERM analog of raloxifene) on tumor suppressor proteins and proliferation of breast cancer cells. Dinda S; Sanchez A; Moudgil VK Horm Mol Biol Clin Investig; 2010 Aug; 2(1):211-7. PubMed ID: 25961194 [TBL] [Abstract][Full Text] [Related]
14. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093 [TBL] [Abstract][Full Text] [Related]
15. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line. Hurd C; Khattree N; Alban P; Nag K; Jhanwar SC; Dinda S; Moudgil VK J Biol Chem; 1995 Dec; 270(48):28507-10. PubMed ID: 7499360 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
17. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Gong Y; Ballejo G; Murphy LC; Murphy LJ Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100 [TBL] [Abstract][Full Text] [Related]
19. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells. Marsaud V; Gougelet A; Maillard S; Renoir JM Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746 [TBL] [Abstract][Full Text] [Related]
20. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Foster JS; Wimalasena J Mol Endocrinol; 1996 May; 10(5):488-98. PubMed ID: 8732680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]